Add to ORKGSerious infections by methicillin-resistant staphylococci, 26 caused by Staphylococcus aureus and two by coagulase-negative staphylococci, were treated with teicoplanin 200-800 mg daily, in eight cases supplemented with another antibiotic. The overall rate of clinical cure or improvement was 75%, and that of bacterial eradication 67%
Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is increasing. V...
In a prospective, randomized trial, teicoplanin (at a 400-mg intravenous loading dose followed by 20...
ABSTRACf: Teicoplanin is a new glycopeptideantibiotic with potent activityagainst gram-positivebacte...
Teicoplanin, 200-400 mg (3-6 mg/kg) daily iv or im, was used to treat 71 episodes of infection. The ...
Twenty-five patients with ccllulitis or other soft tissue infections were treated with once daily te...
Brusseb, Belgium Twenty-one patients were included in an open randomized study comparing vancomycin ...
The prophylactic and therapeutic activities of teicoplanin were evaluated in two different experimen...
Intravenous teicoplanin has been used to treat 23 cases of gram-positive-bacterial endocarditis, usu...
Infective endocarditis is an uncommon disease but retains a high mortality. Glycopeptides are used f...
Teicoplanin is a new antibiotic obtained from a culture filtrate of Actinoplanes teichomyceticus wit...
Oxacillin-resistant staphylococci are the most serious pathogens in chronic osteomyelitis and only g...
Treatment of difficult-to-treat infections such as osteomyelitis or infections related to indwelling...
Of 41 methicillin-resistant coagulase-negative staphylococcal clinical isolates collected during a 5...
Treatment of difficult-to-treat infections such as osteomyelitis or infections related to indwelling...
Only minimal information exists regarding the treatment outcomes of patients suffering from methicil...
Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is increasing. V...
In a prospective, randomized trial, teicoplanin (at a 400-mg intravenous loading dose followed by 20...
ABSTRACf: Teicoplanin is a new glycopeptideantibiotic with potent activityagainst gram-positivebacte...
Teicoplanin, 200-400 mg (3-6 mg/kg) daily iv or im, was used to treat 71 episodes of infection. The ...
Twenty-five patients with ccllulitis or other soft tissue infections were treated with once daily te...
Brusseb, Belgium Twenty-one patients were included in an open randomized study comparing vancomycin ...
The prophylactic and therapeutic activities of teicoplanin were evaluated in two different experimen...
Intravenous teicoplanin has been used to treat 23 cases of gram-positive-bacterial endocarditis, usu...
Infective endocarditis is an uncommon disease but retains a high mortality. Glycopeptides are used f...
Teicoplanin is a new antibiotic obtained from a culture filtrate of Actinoplanes teichomyceticus wit...
Oxacillin-resistant staphylococci are the most serious pathogens in chronic osteomyelitis and only g...
Treatment of difficult-to-treat infections such as osteomyelitis or infections related to indwelling...
Of 41 methicillin-resistant coagulase-negative staphylococcal clinical isolates collected during a 5...
Treatment of difficult-to-treat infections such as osteomyelitis or infections related to indwelling...
Only minimal information exists regarding the treatment outcomes of patients suffering from methicil...
Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is increasing. V...
In a prospective, randomized trial, teicoplanin (at a 400-mg intravenous loading dose followed by 20...
ABSTRACf: Teicoplanin is a new glycopeptideantibiotic with potent activityagainst gram-positivebacte...